Building of a prediction model for liver toxicity and hepatocarcinogenicity based on SELDI-TOF MS spectra

被引：0
|
作者：
Beyer, S
Ittrich, C
Kopp-Schneider, A
Kramer, PJ
Hellmann, J
Kröger, M
机构：
[1] Merck KGaA, Inst Tox, D-64293 Darmstadt, Germany
[2] DKFZ, D-69009 Heidelberg, Germany
来源：
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY | 2006年 / 372卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：123 / 123
页数：1
相关论文
共 50 条
  • [1] In-source decay causes artifacts in SELDI-TOF MS spectra
    Ekblad, Lars
    Baldetorp, Bo
    Ferno, Marten
    Olsson, Hakan
    Bratt, Charlotte
    JOURNAL OF PROTEOME RESEARCH, 2007, 6 (04) : 1609 - 1614
  • [2] PROTEOMIC BIOMARKERS IN ASSESSMENT OF LIVER FIBROSIS USING SELDI-TOF MS
    Karatayli, Senem C.
    Mizrak, Dilsa
    Arslan, Muyesser
    Ozkan, Muhip
    Savas, Berna
    Yurdaydin, Cihan
    Idilman, Ramazan
    Bozdayi, A. Mithat
    HEPATOLOGY, 2009, 50 (04) : 842A - 843A
  • [3] SELDI-TOF MS for diagnostic proteomics.
    Issaq, HJ
    Conrads, TP
    Prieto, DA
    Tirumalai, R
    Veenstra, TD
    ANALYTICAL CHEMISTRY, 2003, 75 (07) : 148A - 155A
  • [4] SELDI-TOF MS proteomics in breast cancer
    Zeidan B.A.
    Cutress R.I.
    Hastie C.
    Mirnezami A.H.
    Packham G.
    Townsend P.A.
    Clinical Proteomics, 2009, 5 (3-4) : 133 - 147
  • [5] SELDI-TOF MS detection of urinary hepcidin
    Altamura, Sandro
    Kiss, Judit
    Blattmann, Claudia
    Gilles, Wolfgang
    Muckenthaler, Martina U.
    BIOCHIMIE, 2009, 91 (10) : 1335 - 1338
  • [6] SELDI-TOF MS to determine warfarin dosing regimens
    不详
    BIOANALYSIS, 2010, 2 (04) : 701 - 701
  • [7] Potential proteomic biomarkers in assessing liver fibrosis using SELDI-TOF MS
    Karatayli, Senem Ceren
    Alagoz, S. Gokce
    Mizrak, Dilsa
    Sayki, Muyesser
    Ozkan, Muhip
    Savas, Berna
    Erden, Esra
    Cinar, Kubilay
    Idilman, Ramazan
    Yurdaydin, Cihan
    Bozdayi, A. Mithat
    TURKISH JOURNAL OF GASTROENTEROLOGY, 2012, 23 (01): : 46 - 53
  • [8] POTENTIAL PROTEOMIC BIOMARKERS IN ASSESSING LIVER FIBROSIS USING SELDI-TOF MS
    Karatayli, S. C. Ozen
    Mizrak, D.
    Sayki, M.
    Ozkan, M.
    Erden, E.
    Yurdaydin, C.
    Idilman, R.
    Bozdayi, A. M.
    JOURNAL OF HEPATOLOGY, 2009, 50 : S112 - S112
  • [9] SELDI-TOF mass spectra: A view on sources of variation
    Dijkstra, Martijn
    Vonk, Roel J.
    Jansen, Ritsert C.
    JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2007, 847 (01): : 12 - 23
  • [10] Benchmarking currently available SELDI-TOF MS preprocessing techniques
    Emanuele, Vincent A., II
    Gurbaxani, Brian M.
    PROTEOMICS, 2009, 9 (07) : 1754 - 1762
12345